We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$418M
AUM Growth
+$15.7M
Cap. Flow
+$2.3M
Cap. Flow %
0.55%
Top 10 Hldgs %
29.42%
Holding
120
New
4
Increased
36
Reduced
38
Closed
4

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$685K
2
COP icon
ConocoPhillips
COP
+$543K
3
MRK icon
Merck
MRK
+$356K
4
DHI icon
D.R. Horton
DHI
+$298K
5
UPS icon
United Parcel Service
UPS
+$291K

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$480K
2
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$396K
3
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$357K
4
MSFT icon
Microsoft
MSFT
+$243K
5
YUMC icon
Yum China
YUMC
+$224K

Sector Composition

Rank Sector Weight
1 Technology 15.41%
2 Consumer Staples 11.33%
3 Healthcare 11.05%
4 Financials 10.56%
5 Industrials 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWF icon
101
iShares Russell 1000 Growth ETF
IWF
$121B
$273K 0.07%
2,572
-316
-11% -$30.2K
BA icon
102
Boeing
BA
$171B
$272K 0.07%
1,300
– –
IWB icon
103
iShares Russell 1000 ETF
IWB
$48.2B
$260K 0.06%
768
– –
MAS icon
104
Masco
MAS
$14.1B
$257K 0.06%
4,000
– –
AXP icon
105
American Express
AXP
$227B
$255K 0.06%
800
– –
NUE icon
106
Nucor
NUE
$58.6B
$250K 0.06%
1,936
– –
RTX icon
107
RTX Corp
RTX
$290B
$238K 0.06%
1,635
-35
-2% -$4.66K
UNH icon
108
UnitedHealth
UNH
$376B
$230K 0.06%
740
– –
GD icon
109
General Dynamics
GD
$104B
$224K 0.05%
770
– –
WOR icon
110
Worthington Enterprises
WOR
$2.75B
$222K 0.05%
+3,500
New +$194K
TXN icon
111
Texas Instruments
TXN
$252B
$220K 0.05%
+1,060
New +$188K
LOW icon
112
Lowe's Companies
LOW
$117B
$217K 0.05%
980
– –
GS icon
113
Goldman Sachs
GS
$300B
$212K 0.05%
+300
New +$174K
HPQ icon
114
HP
HPQ
$24.9B
$212K 0.05%
8,680
– –
A icon
115
Agilent Technologies
A
$39.1B
$204K 0.05%
1,737
-104
-6% -$11.5K
ESBA icon
116
Empire State Realty Series ES
ESBA
$1.34B
$84K 0.02%
10,754
– –
AFL icon
117
Aflac
AFL
$64.9B
– –
-1,880
Closed -$209K
CLX icon
118
Clorox
CLX
$11.6B
– –
-1,375
Closed -$202K
WEC icon
119
WEC Energy
WEC
$35.7B
– –
-1,902
Closed -$207K
YUMC icon
120
Yum China
YUMC
$16.5B
– –
-4,320
Closed -$224K
1 2 3 4
5

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return

Boston Research & Management's Q2 2025 Portfolio in Review

As of Q2 2025, Boston Research & Management held 120 positions worth $418M, up 3.9% from $403M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Boston Research & Management's Q2 2025 filing shows 4 new, 36 increased, 38 reduced and 4 closed positions. Its largest new stake was GE Vernova: 600 shares worth $317K. The largest sale was iShares Core S&P 500 ETF, an estimated $480K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Boston Research & Management's largest Q2 2025 buy was GE Vernova: 600 shares worth $317K.
  • Boston Research & Management added most to Thermo Fisher Scientific in Q2 2025, an estimated $685K increase.
  • Boston Research & Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $480K.
  • Boston Research & Management fully exited Yum China in Q2 2025, selling an estimated $224K.
  • Boston Research & Management's ten largest holdings make up 29% of its $418M portfolio in Q2 2025.
  • Boston Research & Management opened 4 new positions and closed 4 in Q2 2025.
  • Boston Research & Management's portfolio value rose 3.9% quarter-over-quarter to $418M.

Based on Boston Research & Management's 13F filing for Q2 2025, filed 12 Aug 2025.